Merus Labs International Inc (TSE:MSL) Receives Average Recommendation of “Hold” from Analysts

Merus Labs International Inc (TSE:MSL) (NASDAQ:MSLI) has been given an average recommendation of “Hold” by the seven ratings firms that are currently covering the firm, MarketBeat.com reports. Three investment analysts have rated the stock with a hold recommendation and one has assigned a buy recommendation to the company. The average 12 month price target among brokers that have covered the stock in the last year is C$1.99.

Several brokerages recently issued reports on MSL. Scotiabank increased their target price on shares of Merus Labs International from C$1.25 to C$1.65 and gave the stock a “sector perform” rating in a research note on Friday, May 12th. TD Securities cut their target price on shares of Merus Labs International from C$3.00 to C$1.65 and set a “tender” rating on the stock in a research note on Friday, May 12th. Finally, CIBC increased their target price on shares of Merus Labs International from C$1.40 to C$1.65 in a research note on Monday, May 15th.

Merus Labs International (TSE:MSL) traded up 0.61% during midday trading on Tuesday, reaching $1.65. 21,976 shares of the company traded hands. Merus Labs International has a 12-month low of $0.95 and a 12-month high of $1.76. The company has a 50 day moving average of $1.63 and a 200-day moving average of $1.30.

TRADEMARK VIOLATION NOTICE: This piece was reported by Community Financial News and is the property of of Community Financial News. If you are reading this piece on another site, it was illegally copied and republished in violation of United States & international trademark and copyright legislation. The original version of this piece can be viewed at https://www.com-unik.info/2017/08/19/merus-labs-international-inc-tsemsl-receives-average-recommendation-of-hold-from-analysts-updated.html.

About Merus Labs International

Merus Labs International Inc is a specialty pharmaceutical company. The Company is engaged in the acquisition and licensing of branded prescription pharmaceutical products. The Company’s products include Elantan, Isoket, Deponit, Sintrom, Emselex/Enablex, Surgestone, Provames, Speciafoldine, Tredemine, Salagen, Estraderm MX and Vancocin.

Analyst Recommendations for Merus Labs International (TSE:MSL)

What are top analysts saying about Merus Labs International Inc? - Enter your email address in the form below to receive our free daily email newsletter that contains the latest headlines and analysts' recommendations for for Merus Labs International Inc and related companies.

Comments

Leave a Reply


share news on Facebook
tweet this investment news
share on linkedin
share on StockTwits
share on Google Plus
share on reddit